1996
DOI: 10.1016/0165-2478(96)02605-3
|View full text |Cite
|
Sign up to set email alerts
|

Activated gamma/delta T lymphocytes infiltrating renal cell carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
10
0

Year Published

2002
2002
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(12 citation statements)
references
References 21 publications
2
10
0
Order By: Relevance
“…This result was also in accordance with the low levels of intratumoral γδ T cells in other solid tumors, such as renal cancer (Kowalczyk et al, 1996;Inman et al, 2008). In the tumoral tissues, we found that the number of γδ T cells was positively associated with OS when patients were defined as following subgroups: patients with earlystage (BCLC stage A) HCC, or with single tumor, or with well differentiated tumor, or without thrombi, which indicated that the important antitumor role of γδ T cells in early-stage HCC.…”
Section: Discussionsupporting
confidence: 72%
“…This result was also in accordance with the low levels of intratumoral γδ T cells in other solid tumors, such as renal cancer (Kowalczyk et al, 1996;Inman et al, 2008). In the tumoral tissues, we found that the number of γδ T cells was positively associated with OS when patients were defined as following subgroups: patients with earlystage (BCLC stage A) HCC, or with single tumor, or with well differentiated tumor, or without thrombi, which indicated that the important antitumor role of γδ T cells in early-stage HCC.…”
Section: Discussionsupporting
confidence: 72%
“…CD8 cells, which can destroy tumour cells, have been studied for over two decades. [15][16][17][18] Our previous studies characterized the genomic expression profiles of the CD3 cells obtained from TILs. 8 In this study, CD8 cells from TILs obtained from the same liver cancer specimens were analysed for gene expression profiles.…”
Section: Discussionmentioning
confidence: 99%
“…The rationale for this approach has been primarily predicated on: 1) a reported relative abundance of ␥␦ T cells in the mononuclear cell infiltrates of RCC tumors (7), 2) associations of ␥␦ T cells with some pathologic features of RCC and (8), and 3) demonstrations that ␥␦ T cells stimulated with pyrophosphate derivatives exhibit cytolytic activity against RCC target cells ex vivo (4,7). Of concern, however, is that much of the impetus for clinical trial testing of ␥␦ T cell adoptive immunotherapy has been provided by way of indirect immunologic studies (5,6), typically involving very small numbers of patient tumor specimens and often without consideration of RCC tumor subtype (4,(7)(8)(9)(10).…”
mentioning
confidence: 99%